Contraception

The ever-use of an intrauterine device (IUD) reduces the risk of ovarian cancer by an average of 30%, according to a rigorous meta-analysis in the Journal of Obstetrics and Gynaecology.

Less than half of ob/gyns offer their patients the two most effective forms of emergency contraception -- ulipristal acetate and the copper intrauterine device (IUD) -- according to a national survey.

Neither the levonorgestrel-releasing intrauterine system (LNG-IUS) nor the copper intrauterine device (IUD) impact the incidence of cellular atypia, but do interfere with the microbiota over time, according to liquid-based cervical cytology and microbiological analyses.

A prospective interventional hospital-based study from India has found that a postpartum intrauterine copper device (PPIUCD) is an efficacious method to reduce the unmet need of contraception.

A summary of key findings from the National Center for Health Statistics (NCHS) recent data brief, No.388, October 2020.

“Telehealth visits serve to ensure patient-centered, shared decision-making counseling, as well as allowing the provider to confirm that the patients are good candidates with no contraindications for their method of choice,” Eve Espey, MD, MPH, said.

Although hypertension is a modifiable risk factor for cardiovascular disease (CVD), certain hormonal contraceptives increase the risk of stroke and myocardial infarction in women with the disorder.

Oral contraceptive pills are a popular choice for many; providers should understand the options to guide patients effectively.

An overwhelming 84% of young women in the United States who reported using contraception chose their method based on factors other than provider recommendation, according to a survey.

Yesterday, on August 11, 2020, the FDA posted the first spreadsheet of adverse event reports.

Transgender and nonbinary people face disproportionate rates of stigma and discrimination in seeking healthcare—and may encounter additional unique barriers in attaining gynecologic and reproductive care.

Ensuring access to safe and effective contraception for postpartum women is an important national goal for India because only one-quarter of the country’s postpartum population is using contraception.

The American Academy of Pediatrics has released new information to improve long-acting reversible contraception (LARC) access for teenagers.

New research suggests levonorgestrel IUDs are successful in treating adolescents with HMB and AUB.

“This wouldn’t have happened if I was still in Brazil!” exclaimed my patient.

Rates of depression at 6 weeks postpartum among adolescents and young adults (AYA) were significantly lower in those initiating immediate postpartum etonogestrel (ENG) implants compared to other birth control methods, according to new research.

Plasma oxytocin levels are significantly higher in oral contraceptive (OC) users than in to non-users, according to a study in Scientific Reports. The cross-sectional study of nearly 200 women also found that scores for satisfaction with life were higher among OC users.

After Medicaid expansion under the Affordable Care Act (ACA), use of insurance for visits to safety net clinics specifically for contraception increased in all states, according to a recent study.

Computer-assisted motivational interviewing may not be effective for convincing released female inmates to use contraception, according to new research from Contraception.

Women with pregestational diabetes mellitus (DM) who recognize benefits in contraception and preconception care are much more likely to use contraception postpartum, according to a survey in the Journal of Obstetrics, Gynecologic & Neonatal Nursing.

Besides routinely offering postpartum LARC to their patients, ob/gyns must advocate for policies that support these devices.

Research from Perspectives on Sexual and Reproductive indicates that school-based health centers offering comprehensive reproductive services leads to substantially fewer teenage pregnancies, abortions and births.  

Counseling strategies that target women initiating a contraception method, including structured counseling on side effects, tend to increase contraceptive continuation, according to research from BMJ Sexual & Reproductive Health. 

Research from Contraception indicates that a new counseling strategy could lead to enhanced patient satisfaction with their birth control method.

Reproductive-aged women with at least one chronic health condition were twice as likely to use highly effective contraception than women without a chronic condition, according to new research.

Medicaid patients are less likely to receive sterilization at time of cesarean, and the reason may surprise you.

Continuation rates for long-acting reversible contraceptives (LARC) were high in a group of adolescent and young adult (AYA) women, according to a retrospective chart review in the Journal of Pediatric and Adolescent Gynecology.

A JAMA Psychiatry prospective cohort study found that scores for depression were higher among younger adolescents who used oral contraceptives (OCs) than those who did not, but the connection did not remain when all included age groups of the study were combined. 

A recent presentation at the 2019 American Society for Reproductive Medicine Scientific Congress & Expo compared female sexual function (FSF) in three progestin-only contraceptives (POCs) among first-time users.

A recently published study found that providers are more likely to focus on the patient's contraceptive preferences when the patient has interacted with a contraceptive decision-support tool.